Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2114146 | Cancer Letters | 2010 | 7 Pages |
Abstract
By qPCR we found that EDG3 and SHC3 were amplified in 60% of ependymomas but none in choroid plexus papillomas. In ependymomas EDG3 and SHC3 amplification increased Shc3 protein levels while EDG3 was less affected. Both proteins were co-immunoprecipitated from ependymoma and Shc3 was tyrosine phosphorylated thus presumably active. We showed by digestion with N-glycosidase-F that EDG3 was glycosylated indicating that EDG3 protein was not retained in the endoplasmic reticulum. The co-immunoprecipitation of Shc3 and EDG3 proteins from ependymomas with amplification of SHC3 and EDG3 genes suggests that the two proteins co-operate and are important for ependymomas in vivo.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lorenzo Magrassi, Nicola Marziliano, Frediano Inzani, Pamela Cassini, Ilaria Chiaranda, Miran Skrap, Stefano Pizzolito, Cesare Arienta, Eloisa Arbustini,